Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

SRP-9005

Gene therapy (AAV vector) · Gene replacement · developed by Sarepta Therapeutics

Phase 3 Most advanced trial (none active)
SRPT Developer
1 Registered trials

What is SRP-9005?

SRP-9005 (rAAVrh74.MHCK7.hSGCG) is an adeno-associated virus vector gene therapy delivering the human SGCG gene, which encodes gamma-sarcoglycan, for single intravenous infusion. It is studied in limb-girdle muscular dystrophy.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
rAAVrh74.MHCK7.hSGCG
Drug type
Gene therapy (AAV vector)
Mechanism
Gene replacement
Therapy area
Musculoskeletal
Developer
Sarepta Therapeutics, Inc. (SRPT)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 3

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06952686 Phase 3 Muscular Dystrophies, Limb-Girdle Withdrawn SRPT

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Muscular Dystrophies, Limb-Girdle

More from Sarepta Therapeutics

Sources

Updated Nov 1, 2026. Something wrong or missing? Report it on the SRPT page.

Follow SRPT, the company behind SRP-9005

See SRPT's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

SRPT catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.